Literature DB >> 3294179

Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies.

F P Downes1, T J Barrett, J H Green, C H Aloisio, J S Spika, N A Strockbine, I K Wachsmuth.   

Abstract

Shiga-like toxin (SLT-II) was purified to apparent homogeneity from Escherichia coli K-12 strain NM522 containing the cloned toxin genes on recombinant plasmid pEB1. Purification was accomplished by a series of column chromatography techniques: anion-exchange, chromatofocusing, cation-exchange, and monoclonal antibody affinity chromatography. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of the pure toxin showed that SLT-II consisted of A and B subunits with apparent molecular weights of 32,000 and 10,200 +/- 800, respectively. A band of molecular weight 25,000 was also observed after sodium dodecyl sulfate-polyacrylamide gel electrophoresis and identified as the A1 subunit by Western immunoblot analysis with toxin-specific monoclonal antibodies (MAbs). The pI of the purified toxin was 5.2. Approximately 1 pg of pure SLT-II, but was not neutralized by polyclonal antibodies or MAbs to SLT-I. Five hybridomas against SLT-II were produced (BC5 BB12, DC1 EH5, EA5 BA3, ED5 DF3, and GB6 BA4). Culture supernatant fluids containing MAbs from these hybridomas did not neutralize the cytotoxicity of SLT-I or Shiga toxin. Western blot analysis showed that two MAbs (MAb DC1 EH5 and MAb GB6 BA4) recognized the A and A1 subunits of SLT-II and three MAbs (MAb BC5 BB12, MAb EA5 BA3, and MAb ED5 DF3) recognized the B subunit of SLT-II. MAb BC5 BB12 was used to prepare an affinity column for toxin purification.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3294179      PMCID: PMC259503          DOI: 10.1128/iai.56.8.1926-1933.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities.

Authors:  N A Strockbine; L R Marques; J W Newland; H W Smith; R K Holmes; A D O'Brien
Journal:  Infect Immun       Date:  1986-07       Impact factor: 3.441

2.  Production of Shiga-like toxin by Escherichia coli.

Authors:  L R Marques; M A Moore; J G Wells; I K Wachsmuth; A D O'Brien
Journal:  J Infect Dis       Date:  1986-08       Impact factor: 5.226

3.  Shiga-like toxin-converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea.

Authors:  A D O'Brien; J W Newland; S F Miller; R K Holmes; H W Smith; S B Formal
Journal:  Science       Date:  1984-11-09       Impact factor: 47.728

4.  Purification and physicochemical properties of a unique Vero cell cytotoxin from Escherichia coli O157:H7.

Authors:  V V Padhye; F B Kittell; M P Doyle
Journal:  Biochem Biophys Res Commun       Date:  1986-09-14       Impact factor: 3.575

5.  Hemolytic uremic syndrome and diarrhea associated with Escherichia coli O157:H7 in a day care center.

Authors:  J S Spika; J E Parsons; D Nordenberg; J G Wells; R A Gunn; P A Blake
Journal:  J Pediatr       Date:  1986-08       Impact factor: 4.406

6.  Immunodot assay for determining the isotype and light chain type of murine monoclonal antibodies in unconcentrated hybridoma culture supernates.

Authors:  J S McDougal; S W Browning; S Kennedy; D D Moore
Journal:  J Immunol Methods       Date:  1983-10-28       Impact factor: 2.303

7.  Characterization of monoclonal antibodies against Shiga-like toxin from Escherichia coli.

Authors:  N A Strockbine; L R Marques; R K Holmes; A D O'Brien
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

8.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

9.  Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli.

Authors:  A D O'Brien; G D LaVeck
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

10.  The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli.

Authors:  M A Karmali; M Petric; C Lim; P C Fleming; G S Arbus; H Lior
Journal:  J Infect Dis       Date:  1985-05       Impact factor: 5.226

View more
  51 in total

1.  Affinity-based separations and purifications. Patents and literature.

Authors:  J S Dordick
Journal:  Appl Biochem Biotechnol       Date:  1991-01       Impact factor: 2.926

2.  Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization.

Authors:  Cory M Robinson; James F Sinclair; Michael J Smith; Alison D O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-09       Impact factor: 11.205

3.  Molecular damage and induction of proinflammatory cytokines in human endothelial cells exposed to Shiga toxin 1, Shiga toxin 2, and alpha-sarcin.

Authors:  Maurizio Brigotti; Domenica Carnicelli; Elisa Ravanelli; Antonio González Vara; Chiara Martinelli; Roberta R Alfieri; Pier Giorgio Petronini; Piero Sestili
Journal:  Infect Immun       Date:  2007-02-12       Impact factor: 3.441

4.  Identification of three amino acid residues in the B subunit of Shiga toxin and Shiga-like toxin type II that are essential for holotoxin activity.

Authors:  L P Perera; J E Samuel; R K Holmes; A D O'Brien
Journal:  J Bacteriol       Date:  1991-02       Impact factor: 3.490

5.  Impact of free verotoxin testing on epidemiology of diarrhea caused by verotoxin-producing Escherichia coli.

Authors:  K Ramotar; E Henderson; R Szumski; T J Louie
Journal:  J Clin Microbiol       Date:  1995-05       Impact factor: 5.948

6.  Direct detection of verotoxin-producing Escherichia coli in stool samples by PCR.

Authors:  K Ramotar; B Waldhart; D Church; R Szumski; T J Louie
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

7.  Evaluation of oligonucleotide probes for identification of shiga-like-toxin-producing Escherichia coli.

Authors:  H Karch; T Meyer
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

8.  Development and evaluation of enzyme-linked immunosorbent assays for detection of shiga-like toxin I and shiga-like toxin II.

Authors:  F P Downes; J H Green; K Greene; N Strockbine; J G Wells; I K Wachsmuth
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

9.  Production and characterization of protective human antibodies against Shiga toxin 1.

Authors:  Jean Mukherjee; Kerry Chios; Dianne Fishwild; Deborah Hudson; Susan O'Donnell; Stephen M Rich; Arthur Donohue-Rolfe; Saul Tzipori
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality.

Authors:  S W Lindgren; J E Samuel; C K Schmitt; A D O'Brien
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.